{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T22:34:41Z","timestamp":1720737281350},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Drug Information J"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1177\/0092861511435907","type":"journal-article","created":{"date-parts":[[2012,3,2]],"date-time":"2012-03-02T22:50:42Z","timestamp":1330728642000},"page":"207-215","update-policy":"http:\/\/dx.doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Consumer Dynamics in a Nonmature Generic Drugs Market: A Causal Model Explaining Intention to Purchase in Spain"],"prefix":"10.1007","volume":"46","author":[{"given":"M\u00f3nica","family":"G\u00f3mez","sequence":"first","affiliation":[]},{"given":"Mercedes","family":"Rozano","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2012,12,30]]},"reference":[{"issue":"7","key":"46020207_CR1","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1108\/10610420010351385","volume":"9","author":"R Yelkur","year":"2000","unstructured":"Yelkur R. Consumer perceptions of generic products: a Mexican study. J Prod Brand Manage. 2000;9(7):446\u2013456.","journal-title":"J Prod Brand Manage"},{"key":"46020207_CR2","unstructured":"Sheppard A. Generic medicines: essential contributors to the long-term health society. IMS Health. 2010. https:\/\/doi.org\/www.imshealth.com\/imshealth\/Global\/Content\/Document\/Market_Measurement_TL\/Generic_Medicines_GA.pdf"},{"key":"46020207_CR3","unstructured":"Aeseg. Workshop Periodistas-Mercado Gen\u00e9ricos. 2010. https:\/\/doi.org\/www.aeseg.es\/IMS-AESEG%20Workshop%20Periodistas%20Nov2010.pdf. Accessed January 15, 2011."},{"key":"46020207_CR4","unstructured":"Aeseg. Gen\u00e9ricos en Espa\u00f1a. 2010. https:\/\/doi.org\/www.aeseg.es\/aeseg_genericos_en_espana.asp. Accessed January 15, 2011."},{"issue":"14","key":"46020207_CR5","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1001\/archinte.163.14.1673","volume":"163","author":"R Kravitz","year":"2003","unstructured":"Kravitz R, Bell R, Azari R, Kelly-Reif S, Krupat E, Thom D. Direct observation of requests for clinical services in office practice. Arch Intern Med. 2003;163(14):1663\u20131681.","journal-title":"Arch Intern Med"},{"issue":"4","key":"46020207_CR6","first-page":"462","volume":"43","author":"D King","year":"2002","unstructured":"King D, Kanavos P. Encouraging the use of generic medicines: implications for transition economies. Croatian Med J. 2002;43(4):462\u2013469.","journal-title":"Croatian Med J"},{"issue":"11\u201312","key":"46020207_CR7","first-page":"1340","volume":"35","author":"U Dholakia","year":"2001","unstructured":"Dholakia U. A motivational process model of product involvement and consumer risk perception. J Marketing. 2001;35(11-12):1340\u20131360.","journal-title":"J Marketing"},{"issue":"4","key":"46020207_CR8","first-page":"48","volume":"9","author":"NV Carroll","year":"1989","unstructured":"Carroll NV, Wolfang A. Inherent risk and market acceptance of generic drug products. J Health Care Marketing. 1989;9(4):48\u201351.","journal-title":"J Health Care Marketing"},{"issue":"2","key":"46020207_CR9","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1745-6606.1994.tb00855.x","volume":"28","author":"J Ogletorpe","year":"1994","unstructured":"Ogletorpe J, Monroe K. Determinants of perceived health and safety risks of selected hazardous products and activities. J Consumer Affairs. 1994;28(2):326\u2013346.","journal-title":"J Consumer Affairs"},{"issue":"1","key":"46020207_CR10","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1745-6606.1991.tb00284.x","volume":"25","author":"NV Carroll","year":"1991","unstructured":"Carroll NV, Wolfang A. Risk, benefits and generic substitution. J Consumer Affairs. 1991;25(1):110\u2013121.","journal-title":"J Consumer Affairs"},{"issue":"1","key":"46020207_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1745-6606.1986.tb00366.x","volume":"20","author":"NV Carroll","year":"1986","unstructured":"Carroll NV, Siridhara C, Fincham JE. Perceived risks and pharmacists\u2019 generic substitution behaviour. J Consumer Affairs. 1986;20(1):36\u201347.","journal-title":"J Consumer Affairs"},{"issue":"6","key":"46020207_CR12","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1037\/0021-9010.63.6.741","volume":"63","author":"W Bearden","year":"1978","unstructured":"Bearden W, Mason J. Consumer perceived risk and attitudes toward generically prescribed drugs. J Appl Psychol. 1978;63(6):741\u2013747.","journal-title":"J Appl Psychol"},{"issue":"6","key":"46020207_CR13","first-page":"691","volume":"77","author":"S Gonz\u00e1lez","year":"2003","unstructured":"Gonz\u00e1lez S, Gonz\u00e1lez C, D\u00edaz AM. Intenci\u00f3n de compra de medicamentos gen\u00e9ricos por parte de los usuarios de Asturias. Rev Esp Salud Publica. 2003;77(6):691\u2013699.","journal-title":"Rev Esp Salud Publica"},{"issue":"1","key":"46020207_CR14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1086\/208788","volume":"7","author":"ZV Lambert","year":"1980","unstructured":"Lambert ZV, Doering PL, Goldstein E, McCormick WC. Predispositions toward generic drug acceptance. J Consumer Res. 1980;7(1):14\u201323.","journal-title":"J Consumer Res"},{"key":"46020207_CR15","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1086\/208801","volume":"7","author":"W Bearden","year":"1980","unstructured":"Bearden W, Mason J. Determinants of physician and pharmacists\u2019 support of generic drugs. J Consumer Res. 1980;7:121\u2013130.","journal-title":"J Consumer Res"},{"issue":"4","key":"46020207_CR16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1108\/02634509310044243","volume":"11","author":"P Turnbull","year":"1993","unstructured":"Turnbull P, Parson N. Generic prescribing in general medical practice: an attitudinal study of general practitioners. Marketing Intell Plann. 1993;11(4):30\u201340.","journal-title":"Marketing Intell Plann"},{"issue":"1","key":"46020207_CR17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1745-6606.1980.tb00662.x","volume":"14","author":"J Mason","year":"1980","unstructured":"Mason J Bearden W. Generic drugs: consumer, pharmacist and physician perceptions of the issues. J Consumer Affairs. 1980;14(1):193\u2013206.","journal-title":"J Consumer Affairs"},{"issue":"3","key":"46020207_CR18","first-page":"26","volume":"8","author":"DH Tootelian","year":"1988","unstructured":"Tootelian DH, Gaedeke RM, Schlacter J. Branded versus generic prescription drugs: perception of risk, efficacy, safety and value. J Health Care Marketing. 1988;8(3):26\u201329.","journal-title":"J Health Care Marketing"},{"issue":"1","key":"46020207_CR19","doi-asserted-by":"publisher","first-page":"108","DOI":"10.2307\/2555818","volume":"29","author":"J Hellerstein","year":"1988","unstructured":"Hellerstein J. The importance of the physician in the generic versus trade-name prescription decision. RAND J Econ. 1988;29(1):108\u2013136.","journal-title":"RAND J Econ"},{"issue":"2","key":"46020207_CR20","first-page":"55","volume":"7","author":"E Cyryl Run de","year":"2006","unstructured":"Cyryl de Run E, Ng Felix MN. Patented and generic pharmaceutical drugs: perception and prescription. Int J Business Soc. 2006;7(2):55\u201378.","journal-title":"Int J Business Soc"},{"issue":"1","key":"46020207_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/15602210701223963","volume":"7","author":"MA Hassali","year":"2007","unstructured":"Hassali MA, Kong DC, Steward K. Knowledge and perceptions of recent pharmacy graduates about generic medicines. Pharm Educ. 2007;7(1):89\u201395.","journal-title":"Pharm Educ"},{"issue":"4","key":"46020207_CR22","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/1475-6773.00162","volume":"38","author":"M Fisher","year":"2003","unstructured":"Fisher M, Avorn J. Economic consequences of underuse of generic drugs: evidence from Medicaid and implications for prescription drug benefit plans. Health Serv Res. 2003;38(4):1051\u20131064.","journal-title":"Health Serv Res"},{"issue":"4","key":"46020207_CR23","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1023\/A:1012504310953","volume":"19","author":"T Aronsson","year":"2001","unstructured":"Aronsson T, Bergman M, Rudholm N. The impact of generic drug competition on brand name market-shares: evidence from micro data. Rev Ind Organ. 2001;19(4):425\u2013435.","journal-title":"Rev Ind Organ"},{"issue":"3","key":"46020207_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1108\/03090569310026637","volume":"27","author":"RN Stone","year":"1993","unstructured":"Stone RN Gr\u00f8nhaug K. Perceived risk: further considerations for the marketing discipline. Eur J Marketing. 1993;27(3):39\u201350.","journal-title":"Eur J Marketing"},{"issue":"2","key":"46020207_CR25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/mar.4220120205","volume":"12","author":"RN Stone","year":"1995","unstructured":"Stone RN Mason JB. Attitude and risk: exploring the relationship. Psychol Marketing. 1995;12(2):135\u2013153.","journal-title":"Psychol Marketing"},{"issue":"4","key":"46020207_CR26","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1177\/1094670503262955","volume":"4","author":"M Laroche","year":"2004","unstructured":"Laroche M, McDougall GH, Bergeron J, Yang Z. Exploring how intangibility affects perceived risk. J Serv Res. 2004;4(4):373\u2013389.","journal-title":"J Serv Res"},{"issue":"5","key":"46020207_CR27","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/cb.16","volume":"4","author":"M Mourali","year":"2005","unstructured":"Mourali M, Laroche M, Pons F. Antecedents of consumer relative preference for interpersonal information sources in pre-purchase search. J Consumer Behav. 2005;4(5):307\u2013318.","journal-title":"J Consumer Behav"},{"issue":"1","key":"46020207_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1086\/209383","volume":"21","author":"C Park","year":"1994","unstructured":"Park C, Mothersbaugh D Feick L. Consumer knowledge assessment. J Consumer Res. 1994;21(1):71\u201382.","journal-title":"J Consumer Res"},{"issue":"2","key":"46020207_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1300\/J026v13n02_09","volume":"13","author":"M Agrawal","year":"1995","unstructured":"Agrawal M. Warning labels: the role of expertise and perceived risk in pharmaceutical purchase behaviour. Health Marketing Q. 1995;13(2):99\u2013115.","journal-title":"Health Marketing Q"},{"issue":"3","key":"46020207_CR30","first-page":"26","volume":"13","author":"J Allen","year":"1993","unstructured":"Allen J, Butler D. Assessing the effects of donor knowledge and perceived risk on intentions to donate blood. J Health Care Marketing. 1993;13(3):26\u201333.","journal-title":"J Health Care Marketing"},{"key":"46020207_CR31","volume-title":"LISREL VI: Analysis of Linear Structure Relationships by the Method of Maximum Likelihood","author":"KG J\u00f6reskog","year":"1984","unstructured":"J\u00f6reskog KG S\u00f6rbom D. LISREL VI: Analysis of Linear Structure Relationships by the Method of Maximum Likelihood. Chicago: National Educational Resources; 1984."},{"key":"46020207_CR32","first-page":"123","volume-title":"Medicamentos gen\u00e9ricos","author":"JI Centenera","year":"2007","unstructured":"Centenera JI. Importancia de los medicamentos gen\u00e9ricos en el control del gasto. In: L\u00f3pez J, ed. Medicamentos gen\u00e9ricos. Pamplona, Spain: EUNSA; 2007:123\u2013146."},{"issue":"11","key":"46020207_CR33","first-page":"10","volume":"262","author":"L Jarvis","year":"2003","unstructured":"Jarvis L. A generics boom could spell opportunity for API manufacturers. Chem Market Reporter. 2003;262(11):10\u201312.","journal-title":"Chem Market Reporter"},{"issue":"3","key":"46020207_CR34","first-page":"106","volume":"7","author":"A I\u00f1esta","year":"2010","unstructured":"I\u00f1esta A. Gen\u00e9ricos: evoluci\u00f3n y medidas que pueden favorecer el aumento de su prescripci\u00f3n y uso en el sistema Nacional de Salud. Econom\u00eda de la Salud. 2010;7(3):106\u2013110.","journal-title":"Econom\u00eda de la Salud"},{"key":"46020207_CR35","doi-asserted-by":"publisher","DOI":"10.1057\/palgrave.jgm.4940128","volume-title":"Sustaining Generic Medicines Markets in Europe","author":"S Simoens","year":"2006","unstructured":"Simoens S, De Coster S. Sustaining Generic Medicines Markets in Europe. Leuven, Belgium: Research Centre for Pharmaceutical Care and Pharmacoeconomics, University of Leuven; 2006. https:\/\/doi.org\/www.egagenerics.com\/doc\/simoens-report_2006-04.pdf. Accessed May 4, 2009."}],"container-title":["Drug Information Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1177\/0092861511435907.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0092861511435907","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1177\/0092861511435907\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0092861511435907","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1177\/0092861511435907.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T20:41:20Z","timestamp":1597956080000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1177\/0092861511435907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["46020207"],"URL":"https:\/\/doi.org\/10.1177\/0092861511435907","relation":{},"ISSN":["0092-8615","2164-9200"],"issn-type":[{"value":"0092-8615","type":"print"},{"value":"2164-9200","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}